From Smallcap Network 3/9/12
Does Somebody Know Something About ChromaDex?
Don't know if you've been watching ChromaDex (CDXC) or not lately, but there's something strange - in a good way - going on here. The stock had been in a tepid-but-decisive slide for most of February. The last two days, however, have been a different story. The stock's made a clear upside reversal effort and is still going strong.
In my experience, there's usually a reason for everything that happens.... especially in the world of small caps. We sometimes don't know what the reason is until after the fact, but somehow the market still 'knows' beforehand. I have to wonder if the market knows something about ChromaDex now.
I do know its Q4 and full-year earnings announcement is due soon, which may have something to do with the recent buying interest. Though there wasn't a lot of 'new revenue' news in the fourth quarter (most of the really good stuff was in Q3 or in the current quarter), the fourth quarter was the first full quarter the BluScience line was offered by GNC stores. Given how well-adopted it's been by other retailers in the meantime I have to think we'll see at least some fiscal traction for BluScience when fourth quarter numbers are posted.
Anyway, as I was doing some routine follow-up stuff with ChromaDex it struck me... newcomers can get into CDXC at about the same level the intuitional money got into it with the fund-raising from early February. They got theirs at $0.75 a share, and you can get it right now for $0.78. And, I'd be willing to bet if you left a limit order of $0.75 out there long enough, you could get that filled too.
It's not too often you can get the same deal that institutions get. Just sayin'.
